Dopamine versus norepinephrine as the first-line vasopressor in the treatment of cardiogenic shock.
Soo Jin NaJeong Hoon YangRyoung-Eun KoChi Ryang ChungYang Hyun ChoKi Hong ChoiDarae KimTaek Kyu ParkJoo Myung LeeYoung Bin SongJin-Oh ChoiJoo-Yong HahnSeung-Hyuk ChoiHyeon-Cheol GwonPublished in: PloS one (2022)
The use of norepinephrine as a first-line vasopressor was not associated with reductions of in-hospital mortality or arrythmia but could reduce use of additional vasopressors in CS patients.